MABVAX THERAPEUTICS HOLDINGS, INC. of San Diego, CA, a company, filed a Form D exempt-offering notice with the SEC on 2014-05-22. The offering totals $4.6M, of which $4.6M was reported sold. Industry: Biotechnology.
Showing 25 of 36 people.
| Name | Role | Location |
|---|---|---|
| Edward W Cantrall | Director | Palo Alto, CA |
| Steven R Goldring | Director | Palo Alto, CA |
| Richard B Newman | Director | Palo Alto, CA |
| William P Kaplan | Executive Officer | Palo Alto, CA |
| Steven R Schow | Executive Officer | Palo Alto, CA |
| Wendy K Wee | Executive Officer | Palo Alto, CA |
| Michael M Wick | Executive Officer | San Diego, CA |
| Robert Hoffman | Director | Houston, TX |
| Paul Resnick | Executive Officer | Lexington, MA |
| Jeffrey Eisenberg | Director | Framingham, MA |
| Paul V Maier | Director | Deer Park, IL |
| Paul Maier | Director | EL CAJON, CA |
| THOMAS VARVARO | Director | IRVINE, CA |
| Thomas C Varvaro | Director | San Diego, CA |
| J. David Hansen | Director | San Diego, CA |
| J. David Hansen | Executive Officer | San Diego, CA |
| Philip O Livingston | Director | San Diego, CA |
| Philip O Livingston | Executive Officer | San Diego, CA |
| Gregory P Hanson | Executive Officer | San Diego, CA |
| Paul W Resnick | Executive Officer | San Diego, CA |
| Jeffrey F Eisenberg | Director | San Diego, CA |
| Paul W Maffuid | Executive Officer | San Diego, CA |
| Philip Livingston | Director | San Diego, CA |
| Kenneth Cohen | Director | San Diego, CA |
| Gregory Hanson | Director | San Diego, CA |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2018-05-15 | D | $860K | $830K |
| 2018-02-13 | D | $2.8M | $2.8M |
| 2015-04-09 | D | $15.0M | $11.6M |
| 2014-07-10 | D | $5.2M | $5.2M |